As Congress weighs drug price restraints, ICER calls out 'unsupported' increases | BioPharma Dive

Retrieved on: 2021-11-16 17:53:19

Tags for this article:

Click the tags to see associated articles and topics

As Congress weighs drug price restraints, ICER calls out 'unsupported' increases | BioPharma Dive. View article details on hiswai:

Excerpt

Price hikes taken last year by AbbVie on its anti-inflammatory drug Humira increased U.S. healthcare spending by $1.4 billion, ...

Article found on: www.biopharmadive.com